BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 89451)

  • 1. Thymidine sensitivity of cultured leukaemic lymphocytes.
    Fox RM; Piddington SK; Tripp EH; Dudman NP; Tattersall MH
    Lancet; 1979 Aug; 2(8139):391-3. PubMed ID: 89451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential metabolism of thymidine in human lymphoid and melanoma cells in vitro.
    Leyva A; Appel H; Kraal I; Pinedo HM
    Anticancer Res; 1984; 4(3):173-8. PubMed ID: 6087718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular basis for the differential sensitivity of B and T lymphocytes to growth inhibition by thymidine and 5-fluorouracil.
    el-Assouli SM
    Leuk Res; 1985; 9(3):391-8. PubMed ID: 3873586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diverse deoxyribonucleotide profiles in cultured human cells with differential sensitivity to thymidine.
    Leyva A; Appel H; Pinedo HM
    Cancer Biochem Biophys; 1984 Sep; 7(3):231-7. PubMed ID: 6333268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of leukemic human null lymphocytes to deoxynucleosides.
    Fox RM; Tripp EH; Piddington SK; Tattersall MH
    Cancer Res; 1980 Sep; 40(9):3383-6. PubMed ID: 6253063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ecto-adenosine triphosphatase deficiency in cultured human T and null leukemic lymphocytes. A biochemical basis for thymidine sensitivity.
    Fox RM; Piddington SK; Tripp EH; Tattersall MH
    J Clin Invest; 1981 Aug; 68(2):544-52. PubMed ID: 6114965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G1-phase arrest of cultured human leukemic T-cells induced by deoxyadenosine.
    Fox RM; Kefford RF; Tripp EH; Taylor IW
    Cancer Res; 1981 Dec; 41(12 Pt 1):5141-50. PubMed ID: 6272990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of B-cell mitogen-induced and spontaneous thymidine uptake in vitro in chronic B-lymphocytic leukaemia cells.
    Juliusson G; Robèrt KH; Nilsson B; Gahrton G
    Br J Haematol; 1985 Jul; 60(3):429-36. PubMed ID: 2410008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Electrophoretic mobility in acute null cell lymphoblastic leukemia].
    Pavone V; Jirillo E; Specchia G; Loria MP; Liso V
    Boll Ist Sieroter Milan; 1982; 61(3):225-9. PubMed ID: 6985423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of blood platelets in nucleoside metabolism: assay, cellular location and significance of thymidine phosphorylase in human blood.
    Shaw T; Smillie RH; MacPhee DG
    Mutat Res; 1988; 200(1-2):99-116. PubMed ID: 3393166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical basis for the differential sensitivity of human T- and B-lymphocyte lines to 5-fluorouracil.
    Piper AA; Fox RM
    Cancer Res; 1982 Sep; 42(9):3753-60. PubMed ID: 6179610
    [No Abstract]   [Full Text] [Related]  

  • 12. Comments on "The molecular basis for the differential sensitivity of B and T lymphocytes to growth inhibition by thymidine and 5-fluorouracil".
    Srivastava BI
    Leuk Res; 1988; 12(8):699. PubMed ID: 3263551
    [No Abstract]   [Full Text] [Related]  

  • 13. Total and surface-located sialic acid levels in normal and leukaemic lymphocytes: relationship to T and B cell nature and to location in vivo.
    O'Kennedy R; Smyth H; Corrigan A; Clyness M
    Eur J Cancer Clin Oncol; 1982 May; 18(5):437-46. PubMed ID: 6981512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochemical profile of B and T leukaemic lymphocytes with special reference to acute lymphoblastic leukaemia.
    Catovsky D; Galetto J; Okos A; Miliani E; Galton DA
    J Clin Pathol; 1974 Oct; 27(10):767-71. PubMed ID: 4547770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human B lymphocytes show greater susceptibility to H2O2 toxicity than T lymphocytes.
    Farber CM; Liebes LF; Kanganis DN; Silber R
    J Immunol; 1984 May; 132(5):2543-6. PubMed ID: 6609202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymidine as a chemotherapeutic agent: pharmacologic, cytokinetic, and biochemical studies in a patient with T-cell acute lymphocytic leukemia.
    Howell SB; Chu B; Mendelsohn J; Carson DA; Kung FH; Seegmiller JE
    J Natl Cancer Inst; 1980 Aug; 65(2):277-84. PubMed ID: 6967527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulating capacity of blast cells from patients with chronic myelocytic leukaemia, in blastic crisis in 'one-way' mixed lymphoycte reaction: lack of evidence for T lymphoblastic conversion.
    Han T; Gomez GA; Minowada J
    Immunology; 1978 Aug; 35(2):299-305. PubMed ID: 155646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte cholesterol synthesis in chronic lymphocytic leukemia.
    Sanghvi A; Warty V
    Life Sci; 1982 Aug; 31(9):893-8. PubMed ID: 6983639
    [No Abstract]   [Full Text] [Related]  

  • 19. 2',3'-Dideoxycytidine toxicity in cultured human CEM T lymphoblasts: effects of combination with 3'-azido-3'-deoxythymidine and thymidine.
    Törnevik Y; Eriksson S
    Mol Pharmacol; 1990 Aug; 38(2):237-43. PubMed ID: 2166904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in DNA and purine nucleotide synthesis in lymphoid cells and sensitivity to glucocorticoids associated with the impairment of differentiation and immune function in mice during tumor growth. Spleen T- and B-lymphocytes].
    Khramtsova SN; Potapova GI; Dmitrieva LV; Shapot VS
    Biokhimiia; 1986 Apr; 51(4):635-43. PubMed ID: 3085734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.